Page 112 - 202011
P. 112

临床药师在ICU感染性休克患者抗感染治疗中的作用                                                           Δ


                        1 #
        廖玉芳 ,李 飞 ,闫建华 ,司 可(1.重庆市黔江中心医院药学部,重庆 409099;2.重庆市黔江中心医院检
               1*
                                 2
                                         3
        验科,重庆 409099;3.重庆市黔江中心医院重症医学科,重庆 409099)
        中图分类号 R978.1;R969.3         文献标志码 A          文章编号     1001-0408(2020)11-1382-05
        DOI   10.6039/j.issn.1001-0408.2020.11.17

        摘   要   目的:探讨临床药师在重症加强护理病房(ICU)抗感染性休克治疗中的作用。方法:回顾性收集2018年1-12月重庆市
        黔江中心医院ICU收治的感染性休克患者180例,按照临床药师是否全程参与抗感染治疗分为干预组(92例)和对照组(88例)。
        两组患者均根据临床诊断给予常规治疗,在此基础上,临床药师全程参与干预组的抗感染治疗,包括参与药学查房、制订抗感染方
        案、指导护士落实抗感染方案、为患者提供药学监护等。评价两组患者有效性、安全性和抗菌药物临床应用指标(如重点监控药品
        使用比例、疗程、费用等)。结果:干预组患者治愈率(98.91%)显著高于对照组(93.18%),不良反应发生率(8.70%)显著低于对照
        组(23.86%);抗菌药物使用种类更加合理(如干预组和对照组患者碳青霉烯类使用比例分别为20.65%、36.36%,喹诺酮类使用比
        例分别为15.22%、28.41%);干预组患者抗菌药物使用时间[(15.18±2.25)d]显著短于对照组[(19.84±3.81)d],人均抗菌药物费
        用[(2 846.99±712.48)元]显著低于对照组[(3 991.26±577.82)元],以上差异均有统计学意义(P<0.05或P<0.01)。结论:临床药
        师全程参与ICU感染性休克患者的抗感染治疗,为患者提供药学服务,可提高抗感染疗效,减少药品不良反应及药源性疾病的发
        生,优化抗菌药物的应用指标及降低医疗费用。
        关键词     临床药师;重症加强护理病房;感染性休克;抗感染;药学服务

        Role of Clinical Pharmacists in Anti-infective Therapy for Patients with Septic Shock in ICU
        LIAO Yufang ,LI Fei ,YAN Jianhua ,SI Ke(1. Dept. of Pharmacy,Chongqing Qianjiang Central Hospital,
                                          2
                    1
                            1
                                                 3
        Chongqing 409099,China;2. Dept. of Clinical Laboratory,Chongqing Qianjiang Central Hospital,Chongqing
        409099,China;3. Dept. of Critical Care,Chongqing Qianjiang Central Hospital,Chongqing 409099,China)
        ABSTRACT    OBJECTIVE:To explore the role of clinical pharmacists in anti-infective therapy in patients with septic shock in the
        ICU. METHODS:A total of 180 patients with septic shock were retrospectively collected from ICU of Chongqing Qianjiang
        Central Hospital during Jan.-Dec. 2018. According to whether clinical pharmacists participated in anti-infective therapy in the whole
        process,the patients were divided into intervention group(92 cases)and control group(88 cases). Both groups were given routine
        treatment according to clinical diagnosis;on this basis,clinical pharmacists participated in the whole anti-infective therapy of the
        intervention group,including participating in pharmaceutical rounds,formulating anti-infective programs,guiding nurses to
        implement anti-infective plan,and providing pharmaceutical care for patients. The effectiveness,safety and antibiotics clinical use
        indexes(such as proportion,treatment course and cost of key monitored drugs)were evaluated in 2 groups. RESULTS:The cure
        rate of intervention group(98.91%)was significantly higher than that of control group(93.18%),while the incidence of ADR in
        the intervention group (8.70%) was significantly lower than control group (23.86%). The use of antibiotics types was more
        rational(the proportion of carbapenems used in intervention group and control group were 20.65%,36.36%;those of quinolones
        were 15.22%,28.41%,respectively);the duration of antibiotics use in the intervention group [(15.18±2.25)d] was significantly
        shorter than control group [(19.84±3.81)d]. The cost of antibiotics per capita [(2 846.99±712.48)yuan] was significantly lower
        than control group [(3 991.26±577.82)yuan],with statistical significance of all above(P<0.05 or P<0.01). CONCLUSIONS:
        Clinical pharmacists participating in the anti-infective treatment of ICU patients with septic shock and providing pharmaceutical
        care,can improve the anti-infective effect,reduce adverse drug reactions and drug-induced diseases,optimize the use of antibiotics
        and reduce medical cost.
        KEYWORDS     Clinical pharmacist;ICU;Septic shock;Anti-infection;Pharmaceutical care


            感染性休克是临床表现为严重感染导致低血压持                           续存在,且经充分的液体复苏仍难以纠正的急性循环衰

            Δ 基金项目:重庆市黔江区科技计划项目(No.黔科计2018005)              竭。感染性休克可迅速导致严重的组织器官功能损伤,
            *主管药师,硕士。研究方向:临床药学。电话:023-79240186。             主要致死原因为多器官功能衰竭,患者的平均病死率可
        E-mail:117411799@qq.com                             达42.9%,因此早期识别并启动抗感染治疗可降低严重
            # 通信作者:副主任药师。研究方向:临床药学。电话:023-
        79240186。E-mail:17563241@qq.com                     感染和感染性休克的病死率             [1-2] 。感染性休克患者的抗


        ·1382  ·  China Pharmacy 2020 Vol. 31 No. 11                                中国药房    2020年第31卷第11期
   107   108   109   110   111   112   113   114   115   116   117